wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q36859215-DBB78A7F-0ECB-450E-9030-ACC31DC9C8A9
Q36859215-DBB78A7F-0ECB-450E-9030-ACC31DC9C8A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36859215-DBB78A7F-0ECB-450E-9030-ACC31DC9C8A9
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
P2860
Q36859215-DBB78A7F-0ECB-450E-9030-ACC31DC9C8A9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q36859215-DBB78A7F-0ECB-450E-9030-ACC31DC9C8A9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e868b63ecb104a0328ae4215528d1fd7eca314a8
P2860
RETRACTED: Selective inhibition of the platelet-derived growth factor signal transduction pathway by a protein-tyrosine kinase inhibitor of the 2-phenylaminopyrimidine class.